Germany: CSL’s Andembry HTA Submission Offers Critical Indirect Comparison Lessons

 
• By Francesca Bruce
  
German HTA says CSL Behring's Andembry offers aditional benefit for hereditary angioedema compared to Biocryst’s Orladeyo. (Shutterstock)

More from Health Technology Assessment

More from Pink Sheet